Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadine Abdallah

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|November 13, 2024
Up-Front Treatment of Elderly (Age ≥75 Years) and Frail Patients With Multiple MyelomaNadine Abdallah, Shaji K Kumar
Hematology/Oncology Clinics of North America|January 12, 2024
New Therapies on the Horizon for Relapsed Refractory Multiple MyelomaNadine Abdallah, Shaji K Kumar
Therapeutic Advances in Hematology|January 7, 2020
Daratumumab in untreated newly diagnosed multiple myelomaNadine Abdallah, Shaji K Kumar
Oral Oncology|April 2, 2018
Responses in patients receiving sequential paclitaxel post progression on PD1 inhibitorsAmmar Sukari, Misako Nagasaka, Nadine Abdallah
Critical Reviews in Oncology/Hematology|March 18, 2019
Unleash the power of the mighty T cells-basis of adoptive cellular therapyAmmar Sukari, Nadine Abdallah, Misako Nagasaka
Respiratory Medicine|July 29, 2018
The spectrum of pulmonary aspergillosisAmjad Kanj, Nadine Abdallah, Ayman O Soubani
Current Oncology Reports|May 18, 2024
Personalized Treatment of Multiple Myeloma in Frail PatientsJodi J Lipof, Nadine Abdallah, Brea Lipe
Clinical Case Reports|July 11, 2018
Is this really just "fatigue"? A case series of immune-related central adrenal insufficiency secondary to immune checkpoint inhibitorsMisako Nagasaka, Nadine Abdallah, Julie Samantray, et al.
Frontiers in Immunology|October 25, 2024
Bispecific antibody targets and therapies in multiple myelomaMatthew Rees, Nadine Abdallah, Binoy Yohannan, et al.
Mayo Clinic Proceedings|February 7, 2021
Host Factors and Outcomes in Hospitalizations for Pneumocystis Jirovecii Pneumonia in the United StatesAmjad Kanj, Bilal Samhouri, Nadine Abdallah, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Journal of the National Comprehensive Cancer Network : JNCCN|November 13, 2024
Up-Front Treatment of Elderly (Age ≥75 Years) and Frail Patients With Multiple MyelomaNadine Abdallah, Shaji K Kumar
Hematology/Oncology Clinics of North America|January 12, 2024
New Therapies on the Horizon for Relapsed Refractory Multiple MyelomaNadine Abdallah, Shaji K Kumar
Therapeutic Advances in Hematology|January 7, 2020
Daratumumab in untreated newly diagnosed multiple myelomaNadine Abdallah, Shaji K Kumar
Oral Oncology|April 2, 2018
Responses in patients receiving sequential paclitaxel post progression on PD1 inhibitorsAmmar Sukari, Misako Nagasaka, Nadine Abdallah
Critical Reviews in Oncology/Hematology|March 18, 2019
Unleash the power of the mighty T cells-basis of adoptive cellular therapyAmmar Sukari, Nadine Abdallah, Misako Nagasaka
Respiratory Medicine|July 29, 2018
The spectrum of pulmonary aspergillosisAmjad Kanj, Nadine Abdallah, Ayman O Soubani
Current Oncology Reports|May 18, 2024
Personalized Treatment of Multiple Myeloma in Frail PatientsJodi J Lipof, Nadine Abdallah, Brea Lipe
Clinical Case Reports|July 11, 2018
Is this really just "fatigue"? A case series of immune-related central adrenal insufficiency secondary to immune checkpoint inhibitorsMisako Nagasaka, Nadine Abdallah, Julie Samantray, et al.
Frontiers in Immunology|October 25, 2024
Bispecific antibody targets and therapies in multiple myelomaMatthew Rees, Nadine Abdallah, Binoy Yohannan, et al.
Mayo Clinic Proceedings|February 7, 2021
Host Factors and Outcomes in Hospitalizations for Pneumocystis Jirovecii Pneumonia in the United StatesAmjad Kanj, Bilal Samhouri, Nadine Abdallah, et al.
Pageof 6